$163.45 0.7%
Price vs. AI Score (Last 150 days)
Data gathered: December 7

Data Bits

Data Bits Value / Change Benchmark
Job Posts 86 -4.4%
App downloads N/A N/A
Sentiment 50 0%
Webpage traffic 3,770,000 -0.3%
Employee Rating 82 0%
Google Adspend $1,178 -76.9%
Google Trends 59 -26.3%
Linkedin Employees 7,028 N/A
Patents 808 0%
4chan Mentions 0%
Facebook Engagement 247 0%
Facebook followers 163,189 -0.1%
Stocktwits Mentions 2 0%
Stocktwits Subscribers 1,499 0.1%
Twitter Followers 10,186 0%
Youtube Subscribers 37,900 0%
Instagram Followers 3,236 -0%
News Mentions -100%
Reddit Mentions -100%
Business outlook 78 0%

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news


About Resmed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.


Resmed
Price $163.45
Target Price Sign up
Market Cap $24.1B
Dividend Yield 0.0119
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '231.11B734M600M219M298M
Q2 '231.04B741M617M230M284M
Q1 '231.12B736M618M233M309M
Q4 '221.04B681M580M225M287M
Q3 '22967M610M541M210M282M

Insider Transactions

Sandercock Brett filed to sell 92,962 shares at $152.6.
November 29 '23
Farrell Michael J. filed to sell 440,986 shares at $152.
November 16 '23
Rider Michael J filed to sell 7,358 shares at $143.4.
November 2 '23
Farrell Michael J. filed to sell 449,360 shares at $140.7.
October 17 '23
Rider Michael J filed to sell 7,383 shares at $145.9.
October 4 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.